Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Tessier

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Annales De Dermatologie Et De Venereologie|July 9, 2021
French guidelines for the management of oral lichen planus (excluding pharmacological therapy)F Campana, R Lan, C Girard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2024
Oesophageal lichen planus: Clinical, endoscopic and fibroscopic characteristicsA Kayal, M H Tessier, J-C Fricain, et al.
International Journal of Cancer|February 6, 1999
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1M Marchand, N van Baren, P Weynants, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Annales De Dermatologie Et De Venereologie|July 9, 2021
French guidelines for the management of oral lichen planus (excluding pharmacological therapy)F Campana, R Lan, C Girard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2024
Oesophageal lichen planus: Clinical, endoscopic and fibroscopic characteristicsA Kayal, M H Tessier, J-C Fricain, et al.
International Journal of Cancer|February 6, 1999
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1M Marchand, N van Baren, P Weynants, et al.
Pageof 3